[Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026!
Exhibitor: UVAT TECHNOLOGY CO., LTD.
Date: 2026-07-09
Booth No.: N602
Driving Next-Generation Biomedical Devices: Advanced Plasma Surface Modification & Conductive Metal Thin-Film Applications
The diagnostic precision of next-generation biochips and high-end medical devices hinges on the microscopic characteristics of their material surfaces. Ultra-Vacuum Advanced Technology (UVAT) is proud to announce our participation in BIO Asia-Taiwan 2026 this July!
Leveraging our deep-rooted expertise in semiconductor and precision vacuum processing, UVAT will present core solutions in "Plasma Surface Activation & Modification" and "Conductive Metal Thin-Film Applications." We aim to empower global biomedical partners in overcoming manufacturing bottlenecks and accelerating commercialization.
-
Exhibition Date: July 2026
-
Venue: Taipei Nangang Exhibition Center, Taipei, Taiwan
💡 Two Core Technology Solutions on Display
In the development of In Vitro Diagnostics (IVD), microfluidic chips, and wearable medical sensors, developers frequently face challenges such as high substrate hydrophobicity, fluid resistance, and poor biomolecule adhesion. UVAT offers revolutionary, dry vacuum solutions tailored to these pain points:
1. Plasma Surface Activation & Modification —— Achieving Superior Hydrophilicity & Biofunctionalization
Utilizing a purely dry, low-temperature plasma process, this technology is uniquely designed for heat-sensitive medical polymers (e.g., PET, COP, COC) and micro-wires:
-
Microfluidic Optimization: Rapidly enhances channel surface wettability to ensure smooth fluid flow, eliminating diagnostic errors caused by bubble entrapment.
-
Enhanced Biomolecule Immobilization: Boosts the binding efficiency of antibodies, proteins, or DNA probes through precise surface functionalization.
-
Safe & Non-Destructive: Operates entirely without chemical residues or cytotoxicity risks, meeting stringent medical regulatory standards (e.g., ISO 10993).
2. Conductive Metal Thin-Film Applications —— Building the Sensing Core for High-Precision Devices
Utilizing advanced vacuum sputtering technology, UVAT deposits uniform, nano-scale metal layers onto diverse biomedical substrates:
-
High-Purity Precious Metal Sputtering: Supports Gold (Au), Platinum (Pt), and other precious metal deposition to construct dense Biosensing Microelectrode Arrays (MEAs) for IVD and POCT diagnostic chips.
-
Superior Interfacial Adhesion: Proprietary vacuum processes significantly strengthen adhesion between metal films and flexible substrates, withstanding prolonged chemical immersion and the repeated bending required by wearable devices.
🤝 From Lab-Scale Prototyping to Industrial Mass Production
UVAT is dedicated to enhancing surface hydrophilicity, improving biomolecule immobilization, and delivering highly stable coatings alongside advanced surface activation and modification. Beyond offering lab-scale testing and prototyping services during early R&D, we provide full-scale automated mass production equipment (such as Roll-to-Roll sputtering/plasma systems)—making us your premier strategic partner for bridging the gap from laboratory research to commercial-scale manufacturing.
We cordially invite R&D teams, medical device manufacturers, and IVD experts to visit the UVAT booth to discuss your surface modification and coating needs with our technical specialists!
More Exhibitor's Press Release
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
- Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic LONZA / 2026-07-08
- Lonza Expands HPAPI Capacity in Visp,Further Supporting its Position in Payload-Linker Manufacturing LONZA / 2026-07-08
- 20 Years of MDG: From CRO to CIO MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- Accelerating Cell, Gene and Regenerative Medicine Development with an Integrated Platform MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- MDG Connects Japan's Leading Nonclinical Research Resources to Accelerate Advanced Therapies MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- NYCU Pavilion at BIO Asia–Taiwan 2026 NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2026-07-07
- US-Based, Globally Connected: Building a Global Platform for Precision Cancer Testing EG BIOMED US INC. / 2026-07-07
- Advancing First Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 Study of Antroquinonol GOLDEN BIOTECHNOLOGY CORP. / 2026-07-06
- How to Run Clinical Trials Efficiently EFFICIENT PHARMA MANAGEMENT CORP. / 2026-07-03
- Noah AI Announces AI Analyst — Designed for Biopharma Investment and Business Decision-Making SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-07-01
- EG Officially Launches Nationwide Telehealth Platform, Delivering an End-to-End Cancer Testing EG BIOMED US INC. / 2026-07-01
- Comprehensive GMP-Grade Exosome Purification and Quality Control Solutions COLD SPRING BIOTECH CORP. / 2026-07-01
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-01
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-01
- Model-informed CMC Development of Amorphous solid dispersions using continuous melt extrusion GETINGE GROUP TAIWAN CO., LTD. / 2026-07-01
- EffPha – 以專家為核心的臨床試驗受託機構(CRO),協助您的藥物研發 EFFICIENT PHARMA MANAGEMENT CORP. / 2026-06-30